Talk innovation: unlocking technology
A podcast by European Patent Office
125 Episodes
-
The revolution in smart health
Published: 4/11/2023 -
Earth observation for a greener planet
Published: 2/15/2023 -
Patenting trends in hydrogen innovation
Published: 1/17/2023 -
Women in tech: the road to gender equality
Published: 1/10/2023 -
Creating an innovation culture around results
Published: 12/13/2022 -
Differentiating collaboration, convergence and cohesion (Research into patents)
Published: 11/15/2022 -
Inspiring inventors: Carmen Hijosa
Published: 11/2/2022 -
How intellectual property (IP) rights create jobs and prosperity in the EU
Published: 10/18/2022 -
Understanding the business value of SMEs' patent portfolio (Research into patents)
Published: 10/4/2022 -
Patents as loan collateral (Research into patents)
Published: 9/20/2022 -
Towards a concordance map: from patents to trade marks (Research into patents)
Published: 9/6/2022 -
Approaching the deal (IP as key commercial asset)
Published: 7/19/2022 -
Approaching the market (IP as key commercial asset)
Published: 7/5/2022 -
Protecting IP assets: types and scope (IP as key commercial asset)
Published: 6/23/2022 -
Free advice to get you started (IP as key commercial asset)
Published: 6/7/2022 -
Inspiring inventors: Pete and Ben Kibel
Published: 5/31/2022 -
The art of defining the scope of your idea (IP as key commercial asset)
Published: 5/24/2022 -
Deep tech innovation in the EU and US
Published: 5/3/2022 -
Building on intellectual property to create a business: a real case
Published: 4/26/2022 -
Vaccine technologies
Published: 4/19/2022
“Talk innovation: unlocking technology” is brought to you by the European Patent Office (EPO). Expert presenters and guests – including our patent examiners - provide their perspective on technology trends and highlight ground-breaking inventions. Join us to learn more on the role of patents and the intellectual property (IP) system in supporting society and the economy. Opinions expressed by podcast participants are their own and may not reflect the views of the EPO.